NBY
Stablecoin Development CorpPrice
Daily candles with volume.
The Street
last action Nov 2024| Date | Firm | Rating |
|---|---|---|
| Nov 11, 2024 | Ascendiant Capital MAINTAIN | Buy |
| Aug 11, 2023 | Ladenburg Thalmann MAINTAIN | Buy |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
SecBot reports
2 filings · 1 press release · 0 bullish · 0 bearish · 1 mixed · 1 neutral- NEUTRAL 8-KApr 6, 2026
Stablecoin Development Corp (formerly NovaBay Pharmaceuticals) announced updated SKY token…
Monitor future staking yield and SKY token price volatility as key value drivers; assess whether digital asset strategy gains market acceptance given the company's transition from pharmaceuticals to…
- MIXED PRESS RELEASEMar 23, 2026
NovaBay Pharmaceuticals (NBY) is rebranding as Stablecoin Development Corporation (SDEV) following…
Monitor for potential volatility around the April 3 ticker change; assess whether staking rewards translate into measurable revenue; watch for future monetization of SKY holdings or expansion into…
- MIXED DEFA14AMar 2, 2026
NovaBay Pharmaceuticals is seeking stockholder approval for the issuance of shares underlying…
Traders should monitor stockholder vote outcome and potential resolution of litigation, as failure to approve could block $134M in funding critical to the company's digital asset pivot. High…
All NBY filing & press-release reports (3)
- 8-K reportApr 6, 2026
- PRESS-RELEASE reportMar 23, 2026
- DEFA14A reportMar 2, 2026